Novartis to buy US-listed Avidity Biosciences for $12 bln October 27, 2025 by wealthalpha Other news Novartis to buy US-listed Avidity Biosciences for $12 bln Source link Previous News Coforge delivers a stellar Q2 despite uncertainty, but it needs to diversify Next News Nikkei tops 50,000 for first time on Takaichi stimulus hopes, Fed easing bets wealthalpha
Leave A Comment